Tradition Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-166
Closed -$22K 451
2023
Q4
$22K Sell
166
-17
-9% -$2.21K ﹤0.01% 813
2023
Q3
$25K Sell
183
-332
-64% -$45.3K ﹤0.01% 786
2023
Q2
$74K Buy
515
+17
+3% +$2.5K 0.01% 528
2023
Q1
$69K Buy
498
+13
+3% +$1.75K 0.01% 533
2022
Q4
$66K Hold
485
0.01% 467
2022
Q3
$53K Hold
485
0.01% 493
2022
Q2
$64K Hold
485
0.01% 423
2022
Q1
$64K Sell
485
-125
-20% -$15K 0.01% 456
2021
Q4
$71K Sell
610
-90
-13% -$10.6K 0.01% 460
2021
Q3
$84K Hold
700
0.01% 396
2021
Q2
$84K Sell
700
-2
-0.3% -$219 0.01% 420
2021
Q1
$70K Sell
702
-148
-17% -$14.9K 0.01% 372
2020
Q4
$85K Buy
+850
New +$90K 0.02% 317

Other funds holding AZN

Tradition Wealth Management's AZN Position: Q1 2024 in Review

Tradition Wealth Management sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 166 shares — an estimated $22K sold.

Tradition Wealth Management first reported a position in AZN in Q4 2020 and held it in 13 quarters. The position peaked at $85K in Q4 2020. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Tradition Wealth Management reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
  • Tradition Wealth Management sold 166 AstraZeneca shares in Q1 2024, an estimated $22K.
  • Tradition Wealth Management first reported a position in AstraZeneca in Q4 2020 and held it in 13 quarters.
  • Tradition Wealth Management's AstraZeneca position peaked at $85K in Q4 2020.
  • 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Tradition Wealth Management's 13F filing for Q1 2024, filed 13 May 2024.